"They see ARW as contributing cashflow to fund other developments. I guess they must be upbeat about it because it looks more like a cash sink to me. If they have done their sums right I guess they are aquiring it cheaply on a historical basis."
Lol that's the most positive assessment I've heard on ARW for a long time. As an ARW holder, cash flow positive seems like a distant dream. But what would holders know, given ARW has possibly the worst disclosure track record of any company I know. I only hold now because of the deceit of the previous management, I guess no news is better than being fed bs. Nobody seems to have a clue where they're headed, and at what point it might turn around (indeed even if that's on the horizon).
Would certainly be a cheap acquisition if it does begin to generate profits, all that plant cost a packet - but seems to be a big question mark over this.
- Forums
- ASX - By Stock
- Ann: Potential Merger Discussions
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.5¢ |
Change
0.002(2.15%) |
Mkt cap ! $35.89M |
Open | High | Low | Value | Volume |
9.5¢ | 9.6¢ | 9.5¢ | $30.63K | 322.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 411024 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 234495 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 411024 | 0.095 |
3 | 260000 | 0.092 |
1 | 34852 | 0.090 |
3 | 337000 | 0.089 |
1 | 115007 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 234495 | 3 |
0.110 | 30000 | 1 |
0.115 | 235000 | 3 |
0.120 | 39431 | 1 |
0.125 | 17200 | 1 |
Last trade - 14.51pm 27/06/2025 (20 minute delay) ? |
Featured News
TEK (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online